{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:55:14Z","timestamp":1793382914573,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:00:00Z","timestamp":1793836800000},"content-version":"am","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007249","name":"University of Minnesota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U01DA051658"],"award-info":[{"award-number":["U01DA051658"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG3DA057850"],"award-info":[{"award-number":["UG3DA057850"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jpet.2025.103743","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:34:49Z","timestamp":1760099689000},"page":"103743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["An antifentanyl monoclonal antibody reverses fentanyl-induced apnea in pigs"],"prefix":"10.1016","volume":"392","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3395-6776","authenticated-orcid":false,"given":"Carly","family":"Baehr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Hatschbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7810-7519","authenticated-orcid":false,"given":"Jennifer","family":"Vigliaturo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6934-4050","authenticated-orcid":false,"given":"Dustin","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujata","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcellene","family":"Hollingsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derrick","family":"Hau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1899-6558","authenticated-orcid":false,"given":"Ann M.","family":"Decker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5562-1312","authenticated-orcid":false,"given":"Brooke","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Khaimraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Aucoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott P.","family":"Runyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alonso G.P.","family":"Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Pravetoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpet.2025.103743_bib1","first-page":"1","article-title":"Drug overdose deaths in the United States, 2001-2021","volume":"457","author":"Spencer","year":"2022","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.jpet.2025.103743_bib2","series-title":"Provisional Drug Overdose Death Counts","author":"Ahmad","year":"2025"},{"key":"10.1016\/j.jpet.2025.103743_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108838","article-title":"Neurocognitive impairments and brain abnormalities resulting from opioid-related overdoses: a systematic review","volume":"226","author":"Winstanley","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jpet.2025.103743_bib4","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.drugpo.2017.06.005","article-title":"Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic","volume":"46","author":"Fairbairn","year":"2017","journal-title":"Int J Drug Policy"},{"issue":"1","key":"10.1016\/j.jpet.2025.103743_bib5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13011-019-0195-4","article-title":"Higher doses of naloxone are needed in the synthetic opioid era","volume":"14","author":"Moss","year":"2019","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"1","key":"10.1016\/j.jpet.2025.103743_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s13181-019-00735-w","article-title":"Naloxone dosing after opioid overdose in the era of illicitly manufactured fentanyl","volume":"16","author":"Carpenter","year":"2020","journal-title":"J Med Toxicol"},{"issue":"6","key":"10.1016\/j.jpet.2025.103743_bib7","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/jcpt.13462","article-title":"Overdoses due to fentanyl and its analogues (F\/FAs) push naloxone to the limit","volume":"46","author":"Pergolizzi","year":"2021","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"10.1016\/j.jpet.2025.103743_bib8","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1080\/08897077.2021.2010252","article-title":"The need for multiple naloxone administrations for opioid overdose reversals: a review of the literature","volume":"43","author":"Abdelal","year":"2022","journal-title":"Subst Abus"},{"key":"10.1016\/j.jpet.2025.103743_bib9","article-title":"Psychostimulant drug co-ingestion in non-fatal opioid overdose","volume":"10","author":"Shastry","year":"2024","journal-title":"Drug Alcohol Depend Rep"},{"issue":"3","key":"10.1016\/j.jpet.2025.103743_bib10","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1016\/j.jemermed.2023.05.006","article-title":"Systematic review of naloxone dosing and adverse events in the emergency department","volume":"65","author":"Yugar","year":"2023","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jpet.2025.103743_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2024.104323","article-title":"Stronger, longer, better opioid antagonists? Nalmefene is NOT a naloxone replacement","volume":"124","author":"Infante","year":"2024","journal-title":"Int J Drug Policy"},{"issue":"1","key":"10.1016\/j.jpet.2025.103743_bib12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12954-024-00994-z","article-title":"High-dose naloxone formulations are not as essential as we thought","volume":"21","author":"Lemen","year":"2024","journal-title":"Harm Reduct J"},{"issue":"1","key":"10.1016\/j.jpet.2025.103743_bib13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12954-024-00964-5","article-title":"\u201cThey make it too hard and too many hoops to jump\u201d: system and organizational barriers to drug treatment during epidemic rates of opioid overdose","volume":"21","author":"Dickson-Gomez","year":"2024","journal-title":"Harm Reduct J"},{"issue":"23","key":"10.1016\/j.jpet.2025.103743_bib14","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1056\/NEJMra1807054","article-title":"Prevention of opioid overdose","volume":"380","author":"Babu","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jpet.2025.103743_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12954-021-00521-4","article-title":"Factors associated with opioid overdose during medication-assisted treatment: How can we identify individuals at risk?","volume":"18","author":"Au","year":"2021","journal-title":"Harm Reduct J"},{"issue":"1","key":"10.1016\/j.jpet.2025.103743_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/13543784.2023.2173062","article-title":"Immunotherapeutic strategies for treating opioid use disorder and overdose","volume":"32","author":"Luba","year":"2023","journal-title":"Expert Opin Investig Drugs"},{"issue":"10","key":"10.1016\/j.jpet.2025.103743_bib17","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/archgenpsychiatry.2009.128","article-title":"Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial","volume":"66","author":"Martell","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jpet.2025.103743_bib18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.drugalcdep.2014.04.003","article-title":"Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial","volume":"140","author":"Kosten","year":"2014","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"10.1016\/j.jpet.2025.103743_bib19","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.4161\/19420862.2014.976431","article-title":"First human study of a chimeric anti-methamphetamine monoclonal antibody in healthy volunteers","volume":"6","author":"Stevens","year":"2014","journal-title":"MAbs"},{"key":"10.1016\/j.jpet.2025.103743_bib20","doi-asserted-by":"crossref","DOI":"10.1021\/acs.bioconjchem.5b00085","article-title":"Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriers","author":"Jalah","year":"2015","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.jpet.2025.103743_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyu093","article-title":"A conjugate vaccine attenuates morphine- and heroin-induced behavior in rats","author":"Li","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"issue":"25","key":"10.1016\/j.jpet.2025.103743_bib22","doi-asserted-by":"crossref","first-page":"8601","DOI":"10.1021\/jacs.7b03334","article-title":"Development of a clinically viable heroin vaccine","volume":"139","author":"Bremer","year":"2017","journal-title":"J Am Chem Soc"},{"issue":"2","key":"10.1016\/j.jpet.2025.103743_bib23","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1124\/jpet.117.247049","article-title":"Opioid dose- and route-dependent efficacy of oxycodone and heroin vaccines in rats","volume":"365","author":"Raleigh","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpet.2025.103743_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.06.006","article-title":"Effectiveness and selectivity of a heroin conjugate vaccine to attenuate heroin, 6-acetylmorphine, and morphine antinociception in rats: comparison with naltrexone","volume":"204","author":"Schwienteck","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"10.1016\/j.jpet.2025.103743_bib25","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1021\/acscentsci.2c00977","article-title":"Development of an effective monoclonal antibody against heroin and its metabolites reveals therapies have mistargeted 6-monoacetylmorphine and morphine over heroin","volume":"8","author":"Lee","year":"2022","journal-title":"ACS Cent Sci"},{"issue":"11","key":"10.1016\/j.jpet.2025.103743_bib26","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1002\/anie.201511654","article-title":"Combatting synthetic designer opioids: a conjugate vaccine ablates lethal doses of fentanyl class drugs","volume":"55","author":"Bremer","year":"2016","journal-title":"Angew Chem Int Ed Engl"},{"issue":"2","key":"10.1016\/j.jpet.2025.103743_bib27","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1124\/jpet.118.253674","article-title":"A fentanyl vaccine alters fentanyl distribution and protects against fentanyl-induced effects in mice and rats","volume":"368","author":"Raleigh","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpet.2025.103743_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107730","article-title":"Vaccine blunts fentanyl potency in male rhesus monkeys","volume":"158","author":"Tenney","year":"2019","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.jpet.2025.103743_bib29","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/s41386-019-0385-9","article-title":"Conjugate vaccine produces long-lasting attenuation of fentanyl vs. food choice and blocks expression of opioid withdrawal-induced increases in fentanyl choice in rats","volume":"44","author":"Townsend","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.jpet.2025.103743_bib30","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1021\/acs.molpharmaceut.0c00497","article-title":"Novel vaccine that blunts fentanyl effects and sequesters ultrapotent fentanyl analogues","volume":"17","author":"Barrientos","year":"2020","journal-title":"Mol Pharm"},{"issue":"23","key":"10.1016\/j.jpet.2025.103743_bib31","doi-asserted-by":"crossref","first-page":"14647","DOI":"10.1021\/acs.jmedchem.0c01042","article-title":"Therapeutic and prophylactic vaccines to counteract fentanyl use disorders and toxicity","volume":"63","author":"Robinson","year":"2020","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.jpet.2025.103743_bib32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41541-021-00329-0","article-title":"Fentanyl conjugate vaccine by injected or mucosal delivery with dmLT or LTA1 adjuvants implicates IgA in protection from drug challenge","volume":"6","author":"Stone","year":"2021","journal-title":"NPJ Vaccines"},{"issue":"1","key":"10.1016\/j.jpet.2025.103743_bib33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41541-023-00694-y","article-title":"A lipidated TLR7\/8 adjuvant enhances the efficacy of a vaccine against fentanyl in mice","volume":"8","author":"Miller","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jpet.2025.103743_bib34","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.neuropharm.2018.06.026","article-title":"Prophylactic vaccination protects against the development of oxycodone self-administration","volume":"138","author":"Nguyen","year":"2018","journal-title":"Neuropharmacology"},{"issue":"23","key":"10.1016\/j.jpet.2025.103743_bib35","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1016\/j.vaccine.2022.03.053","article-title":"Pre-clinical safety and toxicology profile of a candidate vaccine to treat oxycodone use disorder","volume":"40","author":"Hamid","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.jpet.2025.103743_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108653","article-title":"Pharmacological mechanisms underlying the efficacy of antibodies generated by a vaccine to treat oxycodone use disorder","volume":"195","author":"Raleigh","year":"2021","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.jpet.2025.103743_bib37","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1124\/jpet.120.000014","article-title":"Combining a candidate vaccine for opioid use disorders with extended-release naltrexone increases protection against oxycodone-induced behavioral effects and toxicity","volume":"374","author":"Raleigh","year":"2020","journal-title":"J Pharmacol Exp Ther"},{"issue":"26","key":"10.1016\/j.jpet.2025.103743_bib38","doi-asserted-by":"crossref","first-page":"10489","DOI":"10.1021\/jacs.9b04872","article-title":"Monoclonal antibodies for combating synthetic opioid intoxication","volume":"141","author":"Smith","year":"2019","journal-title":"J Am Chem Soc"},{"issue":"3","key":"10.1016\/j.jpet.2025.103743_bib39","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/jpet.120.000124","article-title":"Monoclonal antibodies counteract opioid-induced behavioral and toxic effects in mice and rats","volume":"375","author":"Baehr","year":"2020","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.jpet.2025.103743_bib40","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2021.1991552","article-title":"Novel chimeric monoclonal antibodies that block fentanyl effects and alter fentanyl biodistribution in mice","volume":"13","author":"Ban","year":"2021","journal-title":"MAbs"},{"issue":"2","key":"10.1016\/j.jpet.2025.103743_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112049","article-title":"A trypanosome-derived immunotherapeutics platform elicits potent high-affinity antibodies, negating the effects of the synthetic opioid fentanyl","volume":"42","author":"Triller","year":"2023","journal-title":"Cell Rep"},{"issue":"6","key":"10.1016\/j.jpet.2025.103743_bib42","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2122507","article-title":"Advancing humanized monoclonal antibody for counteracting fentanyl toxicity towards clinical development","volume":"18","author":"Hicks","year":"2022","journal-title":"Hum Vaccin Immunother"},{"issue":"8","key":"10.1016\/j.jpet.2025.103743_bib43","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00213-025-06751-9","article-title":"A humanized monoclonal antibody attenuates fentanyl self-administration and reverses and prevents fentanyl-induced ventilatory depression in rhesus monkeys","volume":"242","author":"Galbo-Thomma","year":"2025","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.jpet.2025.103743_bib44","doi-asserted-by":"crossref","first-page":"7700","DOI":"10.1038\/s41467-023-43126-0","article-title":"Investigation of monoclonal antibody CSX-1004 for fentanyl overdose","volume":"14","author":"Bremer","year":"2023","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.jpet.2025.103743_bib45","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4049\/jimmunol.2400170","article-title":"Monoclonal antibodies engineered with Fc region mutations to extend protection against fentanyl toxicity","volume":"213","author":"Khaimraj","year":"2024","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jpet.2025.103743_bib46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41541-023-00697-9","article-title":"A TLR7\/8 agonist increases efficacy of anti-fentanyl vaccines in rodent and porcine models","volume":"8","author":"Crouse","year":"2023","journal-title":"NPJ Vaccines"},{"issue":"2","key":"10.1016\/j.jpet.2025.103743_bib47","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/jpet.121.001048","article-title":"Pharmacological profiling of antifentanyl monoclonal antibodies in combination with naloxone in pre- and postexposure models of fentanyl toxicity","volume":"381","author":"Baehr","year":"2022","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"10.1016\/j.jpet.2025.103743_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184876","article-title":"Safety and efficacy of an oxycodone vaccine: addressing some of the unique considerations posed by opioid abuse","volume":"12","author":"Raleigh","year":"2017","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.jpet.2025.103743_bib49","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3181\/00379727-78-19134","article-title":"Blood volume of swine","volume":"78","author":"Hansard","year":"1951","journal-title":"Proc Soc Exp Biol Med"},{"issue":"3","key":"10.1016\/j.jpet.2025.103743_bib50","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/00498254.2014.971093","article-title":"Protein binding of fentanyl and its metabolite nor-fentanyl in human plasma, albumin and \u03b1-1 acid glycoprotein","volume":"45","author":"Bista","year":"2015","journal-title":"Xenobiotica"},{"issue":"5","key":"10.1016\/j.jpet.2025.103743_bib51","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1021\/acsptsci.1c00260","article-title":"Efficacy and selectivity of monovalent and bivalent vaccination strategies to protect against exposure to carfentanil, fentanyl, and their mixtures in rats","volume":"5","author":"Crouse","year":"2022","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"41","key":"10.1016\/j.jpet.2025.103743_bib52","doi-asserted-by":"crossref","first-page":"42506","DOI":"10.1021\/acsomega.4c06617","article-title":"Structure-based engineering of monoclonal antibodies for improved binding to counteract the effects of fentanyl and carfentanil","volume":"9","author":"Rodarte","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.jpet.2025.103743_bib53","article-title":"A humanized monoclonal antibody attenuates carfentanil self-administration in nonhuman primates","volume":"16","author":"Galbo-Thomma","year":"2025","journal-title":"Drug Alcohol Depend Rep"},{"issue":"3","key":"10.1016\/j.jpet.2025.103743_bib54","doi-asserted-by":"crossref","first-page":"860","DOI":"10.4049\/jimmunol.2100204","article-title":"Contribution of antibody-mediated effector functions to the mechanism of efficacy of vaccines for opioid use disorders","volume":"207","author":"Huseby Kelcher","year":"2021","journal-title":"J Immunol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525402560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525402560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:35:31Z","timestamp":1773876931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356525402560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0022356525402560"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103743","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An antifentanyl monoclonal antibody reverses fentanyl-induced apnea in pigs","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103743","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103743"}}